Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ResMed to Announce Fourth Quarter Fiscal Year 2017 Results

RSMDF

PR Newswire

SAN DIEGO, June 29, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today announced it will report its fourth quarter of fiscal year 2017 results on Tuesday, August 1, 2017, after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook.

The earnings webcast is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call can be accessed on ResMed's Investor Relations website at investor.resmed.com. Please go to this section of the website and click on the icon for the "Q4 2017 earnings webcast."

Please note that we do not use outside phone lines to access the earnings call.

International earnings webcast times will be:

Tuesday, August 1, 9:30 p.m.

London

Wednesday, August 2, 6:30 a.m.

Sydney

A replay of the earnings webcast will be accessible on our website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and will be accessible from August 1, 2017, until August 15, 2017, at:

US:

+1 800-585-8367

Outside US:

+1 416-621-4642

Passcode:

48372777

About ResMed

ResMed (NYSE: RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 3 million patients remotely monitored every day. Our 5,000-strong team is committed to creating the world's best tech-driven medical device company – improving quality of life, reducing the impact of chronic disease, and saving healthcare costs in more than 100 countries. ResMed.comFacebookTwitter | LinkedIn.

For media

For investors

Alison Graves

Agnes Lee

+1 858-836-6789

+1 858-836-5971

news@resmed.com 

investorrelations@resmed.com

 

ResMed Inc. logo. (PRNewsFoto/ResMed Inc.)


 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/resmed-to-announce-fourth-quarter-fiscal-year-2017-results-300482154.html

SOURCE ResMed Inc.